Pacific Biosciences Of California (PACB) Amortizatization of Intangibles (2021 - 2022)

Pacific Biosciences Of California's (PACB) quarterly Amortizatization of Intangibles came in at $1.8 million in Q4 2022, up 10.67% year-on-year from $1.6 million in Q4 2021, and up 1.9% quarter-over-quarter from $1.7 million in Q3 2022.

Pacific Biosciences Of California (PACB) Amortizatization of Intangibles (2021 - 2022) Analysis & Trends

Pacific Biosciences Of California's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $1.8 million for Q4 2022.

  • On a quarterly basis, Amortizatization of Intangibles rose 10.67% year-over-year to $1.8 million in Q4 2022; TTM through Dec 2022 was $6.9 million, a N/A change from a year earlier, with the FY2023 full-year figure at $6.8 million, down 1.66% from the prior year.
  • Amortizatization of Intangibles advanced to $1.8 million in Q4 2022 per PACB's latest filing, from $1.7 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.8 million in Q4 2022 and bottomed at $790000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 Pacific Biosciences Of California 415.91 Mn 139.95 Mn 12.84 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 1.77 Mn
Dec 31, 2022 1.77 Mn
Sep 30, 2022 1.74 Mn
Sep 30, 2022 1.74 Mn
Jun 30, 2022 1.72 Mn
Jun 30, 2022 1.72 Mn
Mar 31, 2022 1.70 Mn
Mar 31, 2022 1.70 Mn
Dec 31, 2021 1.60 Mn
Dec 31, 2021 1.60 Mn
Jun 30, 2021 801,000.00
Jun 30, 2021 801,000.00
Mar 31, 2021 790,000.00
Mar 31, 2021 790,000.00